Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medical Purposes

ABSTRACT: Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medical Purposes

PROVIDER: PRJNA1129169 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29630930_1.fastq.gz	Fastqsanger.gz
	SRR29630930_2.fastq.gz	Fastqsanger.gz
	SRR29630931_1.fastq.gz	Fastqsanger.gz
	SRR29630931_2.fastq.gz	Fastqsanger.gz
	SRR29630932_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medical Purposes

Project description:Acute promyelocytic leukemia (APL) is a fulminant form of hematological cancer, representing 5-15% of adult leukemias and also affecting children. It is characterized by the 15:17 chromosomal translocation, which produces the pathogenic retinoic acid receptor (RAR) alpha/promyelocytic leukemia protein (PML) fusion product. Remission of APL was recently achieved using the first chemotherapy-independent oral drug regimen in anticancer therapy, consisting of all-trans retinoic acid (targeting RARalpha) and the arsenic sulphide realgar (targeting PML). A broader use of realgar is, however, hampered by the poor solubility of this mineral. We here describe a scalable pH- and temperature-based solubilization process for realgar. The solution obtained displays higher therapeutic indices compared to other arseni-containing compounds, including opriment and arsenic trioxide (an intravenous chemotherapeutic counterpart), which is in line with the lower toxicity of realgar observed in clinical trials. Our data also show that solubilized realgar can disrupt HIV latency, the main barrier to an HIV/AIDS cure, in CD4 T cells of people living with HIV. This discovery may also open new avenues for designing therapies based on orally administrable arsenic-containing compounds.

2025-04-16 | GSE270992 | GEO

NCI's collection of datasets for Health, Medical, and Biomedical research purposes

Project description:NCI's collection of datasets for Health, Medical, and Biomedical research purposes

| PRJNA873187 | ENA

NCI's collection of datasets for Health, Medical, and Biomedical research purposes

Project description:NCI's collection of datasets for Health, Medical, and Biomedical research purposes

| PRJNA873186 | ENA

medical waste metagenome

Project description:medical waste metagenome

| PRJNA1138881 | ENA

Listeria monocytogenes strain:medical patient | isolate:medical patient

Project description:Listeria monocytogenes strain:medical patient | isolate:medical patient Genome sequencing